65
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial

, , , , , & show all
Pages 2039-2047 | Published online: 29 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jadwiga Najib, Ekaterina Didenko, Daria Meleshkina, Kamila Yusupov, Kateryna Maw, Justin Ramnarain & Maliha Tabassum. (2020) Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder. Current Medical Research and Opinion 36:10, pages 1717-1735.
Read now
Michael Huss, Vanja Sikirica, Amaia Hervas, Jeffrey H Newcorn, Valerie Harpin & Brigitte Robertson. (2016) Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment. Neuropsychiatric Disease and Treatment 12, pages 1085-1101.
Read now

Articles from other publishers (7)

Judy van Stralen, Gurdeep Parhar, Anita Parhar, Valérie Tourjman, Sohail Khattak, Tahira Ahmed, Graeme A. E. Donnelly & Jodan Ratz. (2023) Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate. Journal of Attention Disorders 27:7, pages 743-756.
Crossref
Ole Jakob Storebø, Maja Rosenberg Overby Storm, Johanne Pereira Ribeiro, Maria Skoog, Camilla Groth, Henriette E Callesen, Julie Perrine Schaug, Pernille Darling Rasmussen, Christel-Mie L Huus, Morris Zwi, Richard Kirubakaran, Erik Simonsen & Christian Gluud. (2023) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews 2023:3.
Crossref
David R. Coghill, Tamara Werner-Kiechle, Sepehr Farahbakhshian, Caleb Bliss, Brigitte Robertson & Michael Huss. (2020) Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses. European Child & Adolescent Psychiatry 30:5, pages 809-821.
Crossref
Anna Dölp, Katja Schneider-Momm, Philip Heiser, Christina Clement, Reinhold Rauh, Hans-Willi Clement, Eberhard Schulz & Christian Fleischhaker. (2020) Oligoantigenic Diet Improves Children’s ADHD Rating Scale Scores Reliably in Added Video-Rating. Frontiers in Psychiatry 11.
Crossref
María Eugenia Russi. (2018) Experiencia en la utilización de lisdexanfetamina en el manejo del TDAH de niños y adolescentes. Revista de Psiquiatría Infanto-Juvenil 35:3, pages 241-249.
Crossref
Saurabh Srivastav, Susanne Walitza & Edna Grünblatt. (2017) Emerging role of miRNA in attention deficit hyperactivity disorder: a systematic review. ADHD Attention Deficit and Hyperactivity Disorders 10:1, pages 49-63.
Crossref
Ruiling Luan, Zhiling Mu, Fang Yue & Shaoying He. (2017) Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder. Frontiers in Psychiatry 8.
Crossref